Molecular Epidemiology

Publications

Ebola Hemorrhagic Shock Syndrome-on-a-Chip

Junaid A, Tang H, van Reeuwijk A, Abouleila Y, Wuelfroth P, van Duinen V, Stam W, van Zonneveld AJ, Hankemeier T, and Mashagh A.
iScience. 2020 Jan 24; 23(1): 100765

Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registry

Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee DE, et al.
Eur J Prev Cardiol . 2019 May;26(8):824-835. doi: 10.1177/2047487318825350. Epub 2019 Feb 10.

The exposome and health: Where chemistry meets biology

Vermeulen RCH, Schymanski EL, Barabási AL, Miller GW.
Science 24 Jan 2020: Vol. 367, Issue 6476, pp. 392-396. DOI: 10.1126/science.aay3164

Integration of three-phase microelectroextraction sample preparation into capillary electrophoresis

Oedita A, Duivelshofa B, Lindenburg PW, Hankemeier T.
Journal of Chromatography A, Volume 1610, 11 January 2020, 460570

Advances in Portable Sensing Methodologies for Urban Environments: Understanding Cities from a Mobility Perspective.

Birenboim A, Helbich M, Kwan M.
Special issue of Computers, Environment, and Urban Systems, ongoing.

Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications.

Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, Standl E, Beulens JW.
Eur J Prev Cardiol. 2019 Dec;26(2_suppl):25-32.

Built environmental characteristics and diabetes: a systematic review and meta-analysis.

den Braver NR, Lakerveld J, Rutters F, Schoonmade LJ, Brug J, Beulens JWJ.
BMC Med. 2018 Jan 31;16(1):12.

Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models

Kengne AP, Beulens JW, Peelen LM, ….., Wareham NJ.
Lancet Diabetes Endocrinol. 2014 Jan;2(1):19-29.

Our ultimate goal is that people live healthily for longer

Our ultimate goal is that people live healthily for longer

We know far less about the exposome than we do about the human genome. So far, we only understand about half of the disease burden for which we know the environment plays a role. If we want to prevent people from becoming ill, then we need to understand the other half too. We therefore want to systematically analyse the exposome for the first time. We will start with research into the causes of cardiovascular disease and type 2 diabetes. The techniques and insights from this research will also be applicable to other chronic conditions.

Read More
LinkedinYouTube